Getting Enough Seizure Medicine Matters Most In NCSE

What was studied

This study looked at how adults with non-convulsive status epilepticus (NCSE) were treated in a 6-year ambispective registry, and whether treatment patterns were associated with seizure control, death in the hospital, or worse function at discharge. It included 189 adults with non-anoxic NCSE.

The researchers examined several treatment variables: whether patients received a first-line benzodiazepine, whether anti-seizure medicines were given at too low a dose, and whether treatment was escalated to continuous intravenous anesthetic drugs. They also grouped cases by the cause of NCSE, because different causes may be linked with treatment response and outcome.

What they found

The main finding was that anti-seizure medicine underdosing was associated with worse outcomes. Underdosing was independently associated with a higher likelihood that NCSE would not stop and a higher likelihood of in-hospital death.

By contrast, not giving a first-line benzodiazepine and escalation to continuous intravenous anesthetic drugs were not independently associated with outcomes in the multivariable analyses. In subgroup analyses, the association between underdosing and adverse outcomes was observed more consistently in people with acute primary central nervous system pathology and in etiologies considered non-fatal.

Overall, the study suggests that in NCSE, outcome may be more closely associated with anti-seizure medicine dosing adequacy than with strict adherence to a pre-defined treatment sequence.

Limits of the evidence

This was an observational registry study, not a randomized trial, so it cannot show that underdosing directly caused the worse outcomes. Differences in patients' underlying conditions or other clinical factors may have influenced both treatment decisions and outcomes.

The study included 189 adults from a registry and did not include children, so the results may not apply to all patients. NCSE has many different causes, and the subgroup analyses were exploratory, which means they are less certain. The abstract also does not provide detailed information on how dosing decisions were made in each case.

For families and caregivers

For families, this study suggests that in NCSE, making sure anti-seizure medicines are dosed adequately may be important. It also suggests that the underlying cause of NCSE may matter when thinking about treatment and prognosis, rather than focusing only on whether one fixed treatment sequence was followed.

This does not mean treatment order never matters, and it does not establish the best approach for every patient. But it may help families understand why clinicians consider both the medicine dose and the patient’s underlying brain condition.

What to watch next

Prospective studies, ideally randomized trials, are needed to compare treatment strategies across different NCSE subtypes and help clarify optimal care.

Terms in this summary

non-convulsive status epilepticus (NCSE)

A prolonged seizure state without the usual shaking movements; it may cause confusion, reduced awareness, or subtle symptoms.

anti-seizure medicine (ASM)

A medicine used to stop seizures or prevent them from happening.

benzodiazepine (BDZ)

A type of medicine often used first to stop ongoing seizures quickly.

continuous intravenous anesthetic drugs (CIVADs)

Strong medicines given through a vein continuously to suppress ongoing seizures.

etiology

The underlying cause of a disease or condition.

odds ratio (OR)

A measure used in studies to show how strongly something is linked with an outcome; above 1 suggests a higher likelihood.

confidence interval (CI)

A range that shows the uncertainty around a study estimate.